Filing Details

Accession Number:
0001127602-23-015838
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-17 14:10:35
Reporting Period:
2023-05-15
Accepted Time:
2023-05-17 14:10:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
943819 Resmed Inc RMD Surgical & Medical Instruments & Apparatus (3841) 980152841
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1485164 J. Michael Farrell Resmed Inc.
9001 Spectrum Center Blvd
San Diego CA 92123
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Resmed Common Stock Acquisiton 2023-05-15 5,675 $57.76 442,605 No 4 M Direct
Resmed Common Stock Disposition 2023-05-15 5,675 $232.10 436,930 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Resmed Common Stock ResMed Common Stock Options Disposition 2023-05-15 5,675 $0.00 5,675 $57.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,515 2017-11-11 2023-11-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Resmed Common Stock 0 Indirect Lisette and Michael Farrell Foundation
Resmed Common Stock 4,090 Indirect Lisette and Michael Farrell Family Trust
Footnotes
  1. The transaction was conducted under a Rule 10b5-1 plan adopted November 8, 2021.
  2. This transaction was executed in multiple trades at prices ranging from $231.02 - $232.78. The price reported above reflects the weighted average sale price.
  3. Includes 30.2388 shares of ResMed stock purchased on April 28, 2023, through the ResMed Employee Stock Purchase Plan.
  4. Represents date options first became exercisable. Options vest 1/3 per year.